Brief: BOD Australia Enters Manufacturing And Commercialisation Agreement With IX Biopharma
03/01/2018 22:29
Jan 4 (Reuters) - BOD Australia Ltd BDA.AX :
* ENTERS EXCLUSIVE MANUFACTURING AND COMMERCIALISATION
AGREEMENT
WITH IX BIOPHARMA LTD
* BOD AUSTRALIA TO SUPPLY IX BIOPHARMA WITH A RANGE OF
MEDICINAL
CANNABIS EXTRACTS INCLUDING OILS AND RAW MATERIALS
Source text for Eikon: ID:nASX25MSZ2
Further company coverage: BDA.AX
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on IX Biopharma
See all newsBrief: IX Biopharma Says Co Will Undertake An Internal Restructuring Of Its Consumer Business
Brief: IX Biopharma To Issue 1 MLN New Shares To Anson Properties At S$0.4215 Per Share
Brief: IX Biopharma Says US Government Awards US$41 MLN Contract To Fund Development Of Wafermine
Brief: IX Biopharma To Raise At Least S$6 MLN Via Placement At S$0.198 Per Share
Brief: IX Biopharma Enters Term Sheet For Proposed Joint Venture